Valuence Merger I in a proxy filing seeks shareholder approval for up to nine monthly extensions beyond June 3 as it works to secure a merger agreement.
The SPAC raised $200 million in a March 2022 IPO to pursue an acquisition of a life sciences company based in Asia, though excluding China, Hong Kong and Macau.
CEO and Director Sung Yoon Woo is the founder and CEO of Credian Partners, a private equity firm based in South Korea. Read more.
